To study the translation of these in vitro effects in vivo, we employed pressure overload due to TAC- and PE-mediated hypertrophy induction in mice to assess if the absence of Dysbindin protects the heart from pathological cardiac hypertrophy in vivo. The gene discussed is DTNBP1; the disease is persistent truncus arteriosus.